GLP-1RA therapy vs metformin may offer time-dependent neuroprotection against Parkinson disease among patients with type 2 diabetes.

A community-based multilevel intervention (STRIVE) showed no overall significant effect on BMI z-scores among rural Hispanic children.

Phase 3 PEACE trial data support the accelerated approval of Loargys for the treatment of arginase 1 deficiency in pediatric and adult patients.

Adequate staffing tops the list of factors that can help hospitals reattract the registered nurse (RN) workforce.

Capacitive-resistive monopolar radiofrequency improved sexual function and vaginal health in women with genitourinary syndrome of menopause.

Infants from vegan and vegetarian households have growth patterns similar to those from omnivorous households.

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

Nutritional interventions, particularly supplements, are associated with significant improvements in anxiety among patients with T2D.

Intermittent fasting seems to yield little to no difference in weight loss or quality of life for adults with overweight or obesity.

The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use.

Significant diet-induced weight loss led to sustained declines in bone mineral content and proportional lean mass loss.